Tacrolimus C:D Ratio Measured in Renal Transplant Recipients Treated With Once-daily Prolonged-release Drugs
Condition(s):ImmunosuppressionLast Updated:February 20, 2024Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):ImmunosuppressionLast Updated:February 20, 2024Not yet recruiting
Condition(s):Acute GVHDLast Updated:October 17, 2023Completed
Condition(s):Atopic; DermatitisLast Updated:July 24, 2023Completed
Condition(s):Autoimmune Hemolytic Anemia; Pure Red Cell Aplasia; Evans SyndromeLast Updated:December 3, 2019Unknown status
Condition(s):Transplant;Failure,KidneyLast Updated:February 29, 2024Completed
Condition(s):Liver Transplantation; Immunosuppression; Neurotoxicity; Tremor; TacrolimusLast Updated:January 2, 2024Recruiting
Condition(s):Organ GraftsLast Updated:February 20, 2024Not yet recruiting
Condition(s):KIDNEY TRANSPLANTATIONLast Updated:January 8, 2021Completed
Condition(s):Heart Transplant Failure and RejectionLast Updated:March 7, 2024Active, not recruiting
Condition(s):Pure Red Cell AplasiaLast Updated:May 30, 2018Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.